An innovative organoid model to screen for bacteria and their metabolites that protect against inflammation-induced colonic barrier disruption
mSphere · 2026
DOI: 10.1128/msphere.00926-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, 2026. Verfasst von Nicole Cady und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Organoids, Colon, Bifidobacterium adolescentis, Intestinal Mucosa. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Organoids provide a useful model system to study interactions between gut microbes and the activity of host tissues, including gastrointestinal (GI) barrier function. However, most organoid models have limited capacity to mimic the physiological hypoxia experienced by the colonic epithelium in vivo . While oxygen is required to support respiration in the host cells, many gut microbes are anaerobes that require anoxic conditions to grow. Using an innovative anaerobe co-culture system that maintains constant oxygen concentrations on the basolateral side of colonic epithelial monolayers and anoxic conditions on the luminal side, we demonstrate that colonic monolayers derived from a primary human cell line behaved more like in vivo epithelia when cultivated in the co-culture system than when cultured under ambient oxygen concentrations. We then identified interactions between the colonic epithelium and a strain of Bifidobacterium adolescentis —an oxygen-sensitive species that is prevalent and abundant in the adult gut microbiome. Co-culturing colonic monolayers with Bifidobacterium adolescentis U269-1 in the anoxic apical chamber mitigated loss of the barrier function in monolayers exposed to inflammatory cytokines. We identified indole lactic acid (ILA) as one metabolite from B. adolescentis that provides dose-dependent protection against inflammatory cytokines. Oral administration of ILA was well tolerated in mice and provided protection against immunotherapy-induced (anti-CTLA4) colitis in female, but not male mice. Together, we demonstrated the utility of the co-culture system for screening microbes and their metabolites for interactions with the colonic epithelium, as well as advancing our understanding of interactions between bifidobacteria and host barrier function. IMPORTANCE The present study yielded strong evidence for the beneficial effects of B. adolescentis on the maintenance of colonic barrier function in an asymmetric oxygen system that mimics the colonic environment. The bifidobacterial metabolite indole lactic acid was implicated in this protection both in vitro and in a mouse model. We also refined and scaled the co-culture system to a 96-well plate format to provide the capacity for higher-throughput screening of microbes and microbial metabolites under physiologically relevant conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
- Rogel Cancer Center, University of Michigan, Ann Arbor, USA.
- Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
ORCID-Profile: Nicole Cady, Jonathan Z Sexton, Thomas M Schmidt
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Cady, N., Meyer, S. R., Kim, K., Lo, B. C., So, N., Chen, G. Y., Rosshart, S. P., Shah, Y. M., Núñez, G., Sexton, J. Z., & Schmidt, T. M. (2026). An innovative organoid model to screen for bacteria and their metabolites that protect against inflammation-induced colonic barrier disruption. mSphere. https://doi.org/10.1128/msphere.00926-25
Vancouver
Cady N, Meyer SR, Kim K, Lo BC, So N, Chen GY, et al. An innovative organoid model to screen for bacteria and their metabolites that protect against inflammation-induced colonic barrier disruption. mSphere. 2026. doi:10.1128/msphere.00926-25
BibTeX
@article{Cady2026,
author = {Cady, Nicole and Meyer, Sophia R and Kim, Kwi and Lo, Bernard C and So, Ngai and Chen, Grace Y and Rosshart, Stephan P and Shah, Yatrik M and Núñez, Gabriel and Sexton, Jonathan Z and Schmidt, Thomas M},
title = {An innovative organoid model to screen for bacteria and their metabolites that protect against inflammation-induced colonic barrier disruption},
journal = {mSphere},
year = {2026},
doi = {10.1128/msphere.00926-25}
}
EUVIMED